CTL019
Biological
Novartis Pharma AG
Total Payments
$94,109
Transactions
18
Doctors
5
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $7,245 | 8 | 4 |
| 2017 | $86,864 | 10 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $86,864 | 10 | 92.3% |
| Travel and Lodging | $6,907 | 4 | 7.3% |
| Food and Beverage | $337.94 | 4 | 0.4% |
Top Doctors Receiving Payments for CTL019
Ad
Manufacturing Companies
- Novartis Pharma AG $94,109
Product Information
- Type Biological
- Total Payments $94,109
- Total Doctors 5
- Transactions 18
About CTL019
CTL019 is a biological associated with $94,109 in payments to 5 healthcare providers, recorded across 18 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharma AG.
Payment data is available from 2017 to 2018. In 2018, $7,245 was paid across 8 transactions to 4 doctors.
The most common payment nature for CTL019 is "Royalty or License" ($86,864, 92.3% of total).